{
  "url": "https://openlegislation.uk/eu-regulation-2009-1223/annex-VI",
  "json_url": "https://openlegislation.uk/eu-regulation-2009-1223/annex-VI.json",
  "legislation": "eur/2009/1223",
  "legislation_title": "Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (recast) (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2009-1223",
  "path": "annex/VI",
  "kind": "annex",
  "number": "VI",
  "heading": "LIST OF UV FILTERS ALLOWED IN COSMETIC PRODUCTS",
  "text": "Not required if concentration is 0,5 % or less and when it is used only for product protection purposes.\nFor use as a colorant, see Annex IV, No 143.\nIn case of combined use of zinc oxide and zinc oxide (nano), the sum shall not exceed the limit given in column g.\nIn case of combined use of Titanium Dioxide and Titanium Dioxide (nano), the sum shall not exceed the limit given in column g.\nIn case of combined use of Methylene Bis-Benzotriazolyl Tetramethylbutylphenol and Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (nano), the sum shall not exceed the limit given in column g.\nReference number\nSubstance identification\nConditions\nWording of conditions of use and warnings\nChemical name/INN/XAN\nName of Common Ingredients Glossary\nCAS number\nEC number\nProduct type, body parts\nMaximum concentration in ready for use preparation\nOther\na\nb\nc\nd\ne\nf\ng\nh\ni\n1\n2\nN,N,N-Trimethyl-4-(2-oxoborn-3-ylidenemethyl) anilinium methyl sulfate\nCamphor Benzalkonium Methosulfate\n52793-97-2\n258-190-8\n6 %\n3\nBenzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester/Homosalate\nHomosalate\n118-56-9\n204-260-8\n10 %\n4\n2-Hydroxy-4-methoxybenzophenone/Oxybenzone\nBenzophenone-3\n131-57-7\n205-031-5\nProduct types—\n(a) skin products, other than those listed in paragraph (b), including all propellant and pump spray skin products;\n(b) face products, hand products and lip products (excluding propellant and pump spray face products, hand products and lip products);\n(c) all other cosmetic products.\nFor product types—\n(a) 2.2%;\n(b) 6%;\n(c) 0.5%.\nFor product types (a) and (b), not to be used at more than 0.5% to protect product formulation.\nIf used at 0.5% to protect product formulation, the levels used as UV filter must not exceed, for product types—\n(a) 1.7%;\n(b) 5.5%.\nContains Benzophenone-3\n5\nMoved or deleted\n6\n2-Phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts/Ensulizole\nPhenylbenzimidazole Sulfonic Acid\n27503-81-7\n248-502-0\n8 %(as acid)\n7\n3,3'-(1,4-Phenylenedimethylene) bis(7, 7-dimethyl-2-oxobicyclo-[2.2.1]hept-1-yl-methanesulfonic acid) and its salts/Ecamsule\nTerephthalylidene Dicamphor Sulfonic Acid\n92761-26-7, 90457-82-2\n410-960-6\n10 %(as acid)\n8\n1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione/Avobenzone\nButyl Methoxydibenzoylmethane\n70356-09-1\n274-581-6\n5 %\n9\nalpha-(2-Oxoborn-3-ylidene)-toluene-4-sulphonic acid and its salts\nBenzylidene Camphor Sulfonic Acid\n56039-58-8\n6 % (as acid)\n10\n2-Cyano-3,3-diphenyl acrylic acid, 2-ethylhexyl ester/Octocrilene\nOctocrylene\n6197-30-4\n228-250-8\n10 % (as acid)\n11\nPolymer of N-{(2 and 4)-[(2-oxoborn-3-ylidene)methyl]benzyl} acrylamide\nPolyacrylamidomethyl Benzylidene Camphor\n113783-61-2\n6 %\n12\n2-Ethylhexyl 4-methoxycinnamate/Octinoxate\nEthylhexyl Methoxycinnamate\n5466-77-3\n226-775-7\n10 %\n13\nEthoxylated ethyl-4-aminobenzoate\nPEG-25 PABA\n116242-27-4\n10 %\n14\nIsopentyl-4-methoxycinnamate/Amiloxate\nIsoamyl p-Methoxycinnamate\n71617-10-2\n275-702-5\n10 %\n15\n2,4,6-Trianilino-(p-carbo-2'-ethylhexyl-1'-oxy)-1,3,5-triazine\nEthylhexyl Triazone\n88122-99-0\n402-070-1\n5 %\n16\nPhenol,2-(2H-benzotriazol-2-yl)-4-methyl-6-(2-methyl-3-(1,3,3,3-tetramethyl-1-(trimethylsilyl)oxy)-disiloxanyl)propyl)\nDrometrizole Trisiloxane\n155633-54-8\n15 %\n17\nBenzoic acid, 4,4-((6-((4-(((1,1-dimethylethyl)amino)carbonyl)phenyl)amino)-1,3,5-triazine-2,4-diyl)diimino)bis-, bis (2-ethylhexyl) ester/Iscotrizinol (USAN)\nDiethylhexyl Butamido Triazone\n154702-15-5\n10 %\n...\n...\n...\n...\n...\n...\n...\n20\n2-Ethylhexyl salicylate/Octisalate\nEthylhexyl Salicylate\n118-60-5\n204-263-4\n5 %\n21\n2-Ethylhexyl 4-(dimethylamino)benzoate/Padimate O (USAN:BAN)\nEthylhexyl Dimethyl PABA\n21245-02-3\n244-289-3\n8 %\n22\n2-Hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt/Sulisobenzone\nBenzophenone-4, Benzophenone-5\n4065-45-6/6628-37-1\n223-772-2 / -\n5 % (as acid)\n23\n2,2′-Methylene- bis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)/Bisoctrizole\nMethylene Bis-Benzotriazolyl Tetramethylbutylphenol\n103597-45-1\n403-800-1\n10 %\n23a\n2,2′-Methylene- bis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)/Bisoctrizole\nMethylene Bis-Benzotriazolyl Tetramethylbutylphenol (nano)\n103597-45-1\n403-800-1\n10 %\nNot to be used in applications that may lead to exposure of the end user's lungs by inhalation.\nOnly nanomaterials having the following characteristics are allowed:\nPurity ≥ 98,5 %, with 2,2′-methylene-bis-(6(2H-benzotriazol-2-yl)-4-(isooctyl)phenol) isomer fraction not exceeding 1,5 %;\nSolubility < 5 ng/L in water at 25 °C;\nPartition coefficient (Log Pow): 12,7 at 25 °C;\nUncoated;\nMedian particle size D50 (50 % of the number below this diameter): ≥ 120 nm of mass distribution and/or ≥ 60 nm of number size distribution.\n24\nSodium salt of 2,2'-bis(1,4-phenylene)-1H-benzimidazole-4,6-disulfonic acid) / Bisdisulizole disodium (USAN)\nDisodium Phenyl Dibenzimidazole Tetrasulfonate\n180898-37-7\n429-750-0\n10 % (as acid)\n25\n2,2'-(6-(4-Methoxyphenyl)-1,3,5-triazine-2,4-diyl)bis(5-((2-ethylhexyl)oxy)phenol) / Bemotrizinol\nBis-Ethylhexyloxyphenol Methoxyphenyl Triazine\n187393-00-6\n10 %\n26\nDimethicodiethylbenzalmalonate\nPolysilicone-15\n207574-74-1\n426-000-4\n10 %\n27\nTitanium dioxide\nTitanium Dioxide\n13463-67-7/\n1317-70-0/\n1317-80-2\n236-675-5/\n215-280-1/\n215-282-2\n25 %\n27a\nTitanium dioxide\nTitanium Dioxide (nano)\n13463-67-7/1317-70-0/1317-80-2\n236-675-5/215-280-1/215-282-2\n25 %\nNot to be used in applications that may lead to exposure of the end-user’s lungs by inhalation.\nOnly nanomaterials having the following characteristics are allowed:\npurity ≥ 99 %,\nrutile form, or rutile with up to 5 % anatase, with crystalline structure and physical appearance as clusters of spherical, needle, or lanceolate shapes,\nmedian particle size based on number size distribution ≥ 30 nm,\naspect ratio from 1 to 4,5, and volume specific surface area ≤ 460 m 2 /cm 3 ,\ncoated with Silica, Hydrated Silica, Alumina, Aluminium Hydroxide, Aluminium Stearate, Stearic Acid, Trimethoxycaprylylsilane, Glycerin, Dimethicone, Hydrogen Dimethicone, Simethicone,\nor coated with one of the following combinations:\nSilica at a maximum concentration of 16 % and Cetyl Phosphate at a maximum concentration of 6 %,\nAlumina at a maximum concentration of 7 % and Manganese Dioxide at a maximum concentration of 0,7 % (not to be used in lip products),\nAlumina at a maximum concentration of 3 % and Triethoxycaprylylsilane at a maximum concentration of 9 %,\nphotocatalytic activity ≤ 10 % compared to corresponding non-coated or non-doped reference,\nnanoparticles are photostable in the final formulation.\nFor face products containing Titanium Dioxide (nano) coated with the combination Alumina and Manganese Dioxide:\nNot to be used on the lips.\n28\nBenzoic acid, 2-[-4-(diethylamino)-2-hydroxybenzoyl]-. Hexylester\nDiethylamino Hydroxy benzoyl Hexyl Benzoate\n302776-68-7\n443-860-6\n10 %\n29\n1,3,5-Triazine, 2,4,6-tris[1,1'-biphenyl]-4-yl-, including as nanomaterial\nTris-biphenyl triazine\nTris-biphenyl triazine (nano)\n31274-51-8\n—\n10 %\nNot to be used in sprays.\nOnly nanomaterials having the following characteristics are allowed:\nmedian primary particle size > 80 nm;\nPurity ≥ 98 %;\nUncoated\n30\nZinc oxide\nZinc Oxide\n1314-13-2\n215-222-5\n25 %\nNot to be used in applications that may lead to exposure of the end-user's lungs by inhalation.\n30a\nZinc oxide\nZinc Oxide (nano)\n1314-13-2\n215-222-5\n25 %\nNot to be used in applications that may lead to exposure of the end-user's lungs by inhalation.\nOnly nanomaterials having the following characteristics are allowed:\npurity ≥ 96 %, with wurtzite crystalline structure and physical appearance as clusters that are rod-like, star-like and/or isometric shapes, with impurities consisting only of carbon dioxide and water, whilst any other impurities are less than 1 % in total,\nmedian diameter of the particle number size distribution D50 (50 % of the number below this diameter) > 30 nm and D1 (1 % below this size) > 20 nm,\nwater solubility < 50 mg/L\nuncoated, or coated with triethoxycaprylylsilane, dimethicone, dimethoxydiphenylsilanetriethoxycaprylylsilane cross-polymer, or octyl triethoxy silane.\n31\n3,3′-(1,4-Phenylene)bis(5,6-diphenyl-1,2,4-triazine)\nPhenylene Bis-Diphenyltriazine\n55514-22-2\n700-823-1\n5 %\nNot to be used in applications that may lead to exposure of the end user's lungs by inhalation.\n32\n2-ethoxyethyl (2Z)-2-cyano-2-[3-(3-methoxypropylamino) cyclohex-2-en-1-ylidene]acetate\nMethoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate\n1419401-88-9\n700-860-3\n3 %\nNot to be used in applications that may lead to exposure of the end-user’s lungs by inhalation\nDo not use with nitrosating agents – Maximum nitrosamine content: 50 μg/kg\nKeep in nitrite-free containers\n33\n1,1’-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone\nBis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine\n919803-06-8\n485-100-6\n10%\nIn case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %.\nNot to be used in applications that may lead to exposure of the end user’s lungs by inhalation.\n34\n11,1’-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone\nBis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano)\n919803-06-8\n485-100-6\n10%\nOnly nanomaterials having the following characteristics are allowed:\nPurity ≥ 97 %,\nMedian particle size D50 (50 % of the number below this diameter): ≥ 50 nm of number size distribution.\nNot to be used in applications that may lead to exposure of the end user’s lungs by inhalation.\nIn case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Substituted by Commission Regulation (EU) 2016/1143 of 13 July 2016 amending Annex VI to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance)."
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Inserted by Commission Regulation (EU) 2016/621 of 21 April 2016 amending Annex VI to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance)."
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Inserted by Commission Regulation (EU) 2016/1143 of 13 July 2016 amending Annex VI to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance)."
    },
    {
      "type": "F",
      "label": "F4",
      "text": "Inserted by Commission Regulation (EU) 2018/885 of 20 June 2018 amending Annex VI to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance)."
    },
    {
      "type": "F",
      "label": "F5",
      "text": "Substituted by Commission Regulation (EU) No 344/2013 of 4 April 2013 amending Annexes II, III, V and VI to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance)."
    },
    {
      "type": "F",
      "label": "F6",
      "text": "Substituted by Commission Regulation (EU) 2017/238 of 10 February 2017 amending Annex VI to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products."
    },
    {
      "type": "F",
      "label": "F7",
      "text": "Words in Annex 6 table inserted (21.1.2026) by The Cosmetic Products (Restriction of Chemical Substances) (No. 2) Regulations 2025 (S.I. 2025/901), regs. 1(2), 2(a) (with reg. 3)"
    },
    {
      "type": "F",
      "label": "F8",
      "text": "Words in Annex 6 table substituted (21.1.2026) by The Cosmetic Products (Restriction of Chemical Substances) (No. 2) Regulations 2025 (S.I. 2025/901), regs. 1(2), 2(b) (with reg. 3)"
    },
    {
      "type": "F",
      "label": "F9",
      "text": "Words in Annex 6 table substituted (21.1.2026) by The Cosmetic Products (Restriction of Chemical Substances) (No. 2) Regulations 2025 (S.I. 2025/901), regs. 1(2), 2(c) (with reg. 3)"
    },
    {
      "type": "F",
      "label": "F10",
      "text": "Words in Annex 6 table omitted (E.W.S.) (15.7.2026) by virtue of The Cosmetic Products Regulation (EC) No 1223/2009 (Restriction of Chemical Substances) (Amendment and Transitional Provisions) Regulations 2026 (S.I. 2026/23), regs. 1(2), 2(5) (with reg. 3)"
    },
    {
      "type": "F",
      "label": "F11",
      "text": "Deleted by Commission Regulation (EU) 2015/1298 of 28 July 2015 amending Annexes II and VI to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance)."
    },
    {
      "type": "F",
      "label": "F12",
      "text": "Substituted by Commission Regulation (EU) 2018/885 of 20 June 2018 amending Annex VI to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance)."
    },
    {
      "type": "F",
      "label": "F13",
      "text": "Substituted by Commission Regulation (EU) 2019/1857 of 6 November 2019 amending Annex VI to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance)."
    },
    {
      "type": "F",
      "label": "F14",
      "text": "Inserted by Commission Regulation (EU) No 866/2014 of 8 August 2014 amending Annexes III, V and VI to Regulation (EC) No 1223/2009 of the European Parliament and the Council on cosmetic products (Text with EEA relevance)."
    },
    {
      "type": "F",
      "label": "F15",
      "text": "Inserted by Commission Regulation (EU) 2019/680 of 30 April 2019 amending Annex VI to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance)."
    },
    {
      "type": "F",
      "label": "F16",
      "text": "Inserted by Commission Regulation (EU) 2020/1684 of 12 November 2020 amending Annex VI to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance)."
    },
    {
      "type": "F",
      "label": "F17",
      "text": "Words in Annex 6 inserted (9.8.2023) by The Cosmetic Products (Restriction of Chemical Substances) (No. 2) Regulations 2023 (S.I. 2023/836), regs. 1(2), 3(3), Sch. 2"
    },
    {
      "type": "X",
      "label": "X1",
      "text": "Substituted by Corrigendum to Commission Regulation (EU) No 866/2014 of 8 August 2014 amending Annexes III, V and VI to Regulation (EC) No 1223/2009 of the European Parliament and the Council on cosmetic products (Official Journal of the European Union L 238 of 9 August 2014)."
    },
    {
      "type": "footnote",
      "label": "f1",
      "text": "Not required if concentration is 0,5 % or less and when it is used only for product protection purposes."
    },
    {
      "type": "footnote",
      "label": "f2",
      "text": "In case of combined use of Methylene Bis-Benzotriazolyl Tetramethylbutylphenol and Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (nano), the sum shall not exceed the limit given in column g."
    },
    {
      "type": "footnote",
      "label": "f3",
      "text": "For use as a colorant, see Annex IV, No 143."
    },
    {
      "type": "footnote",
      "label": "f4",
      "text": "In case of combined use of Titanium Dioxide and Titanium Dioxide (nano), the sum shall not exceed the limit given in column g."
    },
    {
      "type": "footnote",
      "label": "f5",
      "text": "In case of combined use of zinc oxide and zinc oxide (nano), the sum shall not exceed the limit given in column g."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2009/1223/annex/VI",
    "retrieved_at": "2026-11-01T14:51:03.124433+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}